Truvestments Capital »

Kalvista Pharmaceuticals shares owned by Truvestments Capital

Quarter-by-quarter ownership of Kalvista Pharmaceuticals (KALV) shares owned by Truvestments Capital from 13F filings

Historical chart of Truvestments Capital investment in Kalvista Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kalvista Pharmaceuticals held by Truvestments Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalvista Pharmaceuticals by Truvestments Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $16k 1.3k 12.18
2025-06-30 $15k 1.3k 11.31

More positions owned by Truvestments Capital

NVIDIA Corporation (NVDA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Broadcom (AVGO)
Apple (AAPL)
Microsoft Corporation (MSFT)
Corning Incorporated (GLW)
Qualcomm (QCOM)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Celestica (CLS)
Nextera Energy (NEE)
Caterpillar (CAT)
Oracle Corporation (ORCL)
Johnson & Johnson (JNJ)
Strategy Cl A New (MSTR)

View all positions for Truvestments Capital

Top funds holding Kalvista Pharmaceuticals

VR Adviser
Tang Capital Management
Frazier Life Sciences Management
Suvretta Capital Management
Capital World Investors
BlackRock
Vanguard Group
Millennium Management
Woodline Partners
Goldman Sachs Group
Parkman Healthcare Partners
Caption Management
State Street Corporation
Silverarc Capital Management
Emerald Advisers

View all funds holding Kalvista Pharmaceuticals